RECRUITINGOBSERVATIONAL
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Orphans Unite: chILD Better Together - European Management Platform for Childhood Interstitial Lung Diseases / chILD-EU - International Register and Biobank for Children´s Interstital Lung Disease
About This Trial
Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes
Who May Be Eligible (Plain English)
Who May Qualify:
- all children with suspected or
- verified diagnosis of ILD or
- masquerading as ILD and
- those with rare localized parenchymal lung diseases
Who Should NOT Join This Trial:
- other indication as inclusion criteria
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* all children with suspected or
* verified diagnosis of ILD or
* masquerading as ILD and
* those with rare localized parenchymal lung diseases
Exclusion Criteria:
* other indication as inclusion criteria
Locations (3)
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
Hacettepe University, Medical Faculty
Ankara, Sihhiye, Turkey (Türkiye)
University of Edinburgh
Edinburgh, United Kingdom